Stay updated on Menin Inhibitor Combo in AML Clinical Trial
Sign up to get notified when there's something new on the Menin Inhibitor Combo in AML Clinical Trial page.

Latest updates to the Menin Inhibitor Combo in AML Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov site revision identifier changed from v3.8.0 to v3.8.1; the study record content appears unchanged.SummaryDifference0.1%

- Check8 days agoChange DetectedThe study record for the SAVE trial is displayed with its study design, treatments, eligibility criteria, and contact information for the recruiting Houston location. Publications, record dates, and study documents are also available.SummaryDifference49%

- Check15 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check29 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence,” and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check43 days agoChange DetectedThe displayed site revision changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check57 days agoChange DetectedThe study record page now displays a 403 Forbidden error instead of the expected content, preventing access to the study details. This appears to be a site-access issue rather than an update to the study information.SummaryDifference18%

Stay in the know with updates to Menin Inhibitor Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Menin Inhibitor Combo in AML Clinical Trial page.